Replies to post #15722 on Synaptogenix Inc (SNPX)

[rayovacAAA]

NTRP RECEIVED ORPHAN DRUG DESIGNATION FOR FRAGILE X IN 2015!!!!!!!!!!!!


OBVIOUSLY THE CURRENT "PANDEMIC" IS WHAT PREVENTED THE TEAM FROM WORKING TOWARD FRAGILE X TRIAL PROTOCOLS THE PREVIOUS 5 YEARS!!!!!!!!!!